Bill Gates has a $100M and a 5-point strategy to end 15 years of failure in Alzheimer’s R&D
Bill Gates is going after Alzheimer’s.
The software billionaire is investing $50 million of his own money — not from the Gates Foundation — into the industry/government backed Dementia Discovery Fund, which set out a couple of years ago to back some translational work on new approaches to the disease. And he tells Reuters that he’s earmarked $50 million more to back new companies on his own that have the potential to tackle some fresh approaches to a disease that has defeated virtually everything thrown at it in the last 15 years.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
